By Jeffrey R. Galas
Last July, an issue with swallowing food caused me to ask why, but I didn’t think twice until it was repeated two more times at three-week intervals. At that time, I moved my annual physical ahead from Oct. 26 to Oct. 6, at which time I insisted to my local doctor of a scope of the area in question. On Oct. 10, it was determined that there was a tumor, and biopsies confirmed a malignant tumor. I was diagnosed with esophageal cancer.
I immediately went online and looked toward Rush University Medical Center. The specialist in Barrett’s esophagus with minimally invasive surgery was Dr. Gary Chmielewski.
Upon meeting him, I knew he was the surgeon I wanted. He requested two more tests to confirm the diagnosis, after which a port was placed in me. On Oct. 25, I had a consultation with the team of doctors who would be handling my case, including Dr. Chmielewski, a thoracic surgeon; Dr. Sohrab Mobarhan, a gastroenterologist; and Dr. William T. Leslie of hematology/oncology.
Dr. Leslie chose the chemo treatment for my case, and surgery would take place after 12 treatments (depending on results). After eight treatments, the results were impressive, and surgery came sooner then anticipated — on Feb. 27, 2012.
By Gary W. Chmielewski, MD
No patient represents the importance of the “mind-body” connection like Jeff Galas.
When I saw Mr. Galas in the fall of 2011 for his newly diagnosed cancer of the esophagus, for all practical purposes on the surface he looked like he would proceed directly to surgical for treatment. On further staging workup, though, he was found to have possible liver metastasis on PET scanning, and at that point surgery was off the table. Chemotherapy would likely be his only option.
When given the dire news, Mr. Galas was his usual positive self and said “Don’t worry, doc, I am going to be the poster child for esophageal cancer. You will be operating on me yet.”
We already had a multidisciplinary team in place consisting of a surgeon, radiation oncologist and a oncologist — so Dr. William Leslie from oncology weighed in on the treatment options. To his credit, instead of recommending the standard agents, he suggested a new regime consisting of FOLFOX that has shown promise in metastatic GI cancers. Mr. Galas sailed through this regime, and when we restaged him, there was no evidence of metastasis.
Being cautiously optimistic, the Coleman Clinic GI team reviewed his case and presented his options of proceeding with radiation treatment or the original option of a minimally invasive esophagectomy if liver biopsy confirmed no disease. Mr. Galas opted for surgery and the minimally invasive approach. At time of laparoscopy, liver biopsy showed no signs of cancer spread to the liver, and a minimally invasive esophagectomy was completed. Mr Galas was home 10 days later, tolerating a diet and resuming many of his normal activities. Because a minimally invasive approach was used, he was able to restart his chemotherapy after only four weeks post-operatively. I am certain Mr. Galas’s positive mindset contributed to his excellent response to date.
Gary W. Chmielewski, MD, is a thoracic surgeon at Rush University Medical Center.